blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3658527

EP3658527 - ACRYLIC ACID ANALOGS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.02.2022
Database last updated on 28.06.2024
FormerRequest for examination was made
Status updated on  01.05.2020
FormerThe international publication has been made
Status updated on  02.02.2019
Most recent event   Tooltip18.02.2022Application deemed to be withdrawnpublished on 23.03.2022  [2022/12]
Applicant(s)For all designated states
Recurium IP Holdings, LLC
10835 Road to the Cure, Suite 205
San Diego, CA 92121 / US
[2020/23]
Inventor(s)01 / HUANG, Peter, Qinhua
10835 Road To The Cure Suite 205
San Diego CA 92121 / US
02 / SLEE, Deborah, Helen
10835 Road To The Cure Suite 205
San Diego CA 92121 / US
03 / BUNKER, Kevin, Duane
10835 Road ToThe Cure Suite 205
San Diego CA 92121 / US
04 / HEGDE, Sayee, Gajanan
10835 Road To The Cure Suite 205
San Diego CA 92121 / US
05 / HOPKINS, Chad, Daniel
10835 Road To The Cure Suite 205
San Diego CA 92121 / US
 [2020/23]
Representative(s)Arth, Hans-Lothar
ABK Patent Attorneys
Jasminweg 9
14052 Berlin / DE
[2020/23]
Application number, filing date18837613.126.07.2018
[2020/23]
WO2018US43935
Priority number, dateUS201762538486P28.07.2017         Original published format: US 201762538486 P
[2020/23]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019023481
Date:31.01.2019
Language:EN
[2019/05]
Type: A1 Application with search report 
No.:EP3658527
Date:03.06.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 31.01.2019 takes the place of the publication of the European patent application.
[2020/23]
Search report(s)International search report - published on:AU31.01.2019
(Supplementary) European search report - dispatched on:EP11.03.2021
ClassificationIPC:C07C59/56, C07C255/57, A61K31/192, A61P35/00, A61P5/32
[2020/23]
CPC:
C07C255/57 (EP,AU,US); C07C59/56 (EP,AU,US); A61P35/00 (EP,AU,US);
A61P5/32 (EP); C07C2602/02 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/23]
TitleGerman:ACRYLSÄURE-ANALOGA[2020/23]
English:ACRYLIC ACID ANALOGS[2020/23]
French:ANALOGUES DE L'ACIDE ACRYLIQUE[2020/23]
Entry into regional phase10.02.2020National basic fee paid 
10.02.2020Search fee paid 
10.02.2020Designation fee(s) paid 
10.02.2020Examination fee paid 
Examination procedure10.02.2020Examination requested  [2020/23]
03.09.2020Amendment by applicant (claims and/or description)
12.10.2021Application deemed to be withdrawn, date of legal effect  [2022/12]
03.11.2021Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2022/12]
Fees paidRenewal fee
14.07.2020Renewal fee patent year 03
15.07.2021Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO2010107475  (UNIV NEW YORK STATE RES FOUND [US], et al) [I] 1-14 * page 105; compound SS1020 * * page 8, line 1 - page 9, line 27 *
International search[X]WO9908682  (UNIV DUKE [US]) [X] 1, 2, 11-14, 16, 30, 31, 34- 36, 41-46, 62-66 & 68 * abstract; page 12, 3rd paragraph; table 1, GW 5638 and GW 7604; and claims 1, 2 and 7 *;
 [A]WO03016270  (BRISTOL MYERS SQUIBB PHARMA CO [US]) [A] 1-68 * abstract; and claim 1 *
 [X]  - LAI, A. et al., "Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts", Journal of Medicinal Chemistry, (20150000), vol. 58, pages 4888 - 4904, XP055319324 [X] 1-14, 16-28, 30-46, 49-66 & 68 * abstract; page 4889, figure 1, compounds 4 and 5, and left column, first paragraph; page 4892, table 2, compounds 5a-c; page 4893, table 3; page 4894, table 4, compounds 10a and 10b; table 5, compounds lla-g and llj-111; and page 4898, conclusion *

DOI:   http://dx.doi.org/10.1021/acs.jmedchem.5b00054
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.